CD44 and breast carcinoma: Liu et al. reported that IGF2BP3 binds to CD44 mRNA and enhances the expression of CD44, thereby increasing the IGF2 level of fibroblasts, the proliferation of breast cancer cells, and the drug resistance of paclitaxel [130].